134 related articles for article (PubMed ID: 24534597)
1. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
Couch KA; Geide T
Am J Health Syst Pharm; 2014 Mar; 71(5):417-24. PubMed ID: 24534597
[TBL] [Abstract][Full Text] [Related]
2. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
Billeter M;
Am J Health Syst Pharm; 2004 Nov; 61(22):2430-5. PubMed ID: 15581268
[TBL] [Abstract][Full Text] [Related]
3. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.
Low DE
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557
[TBL] [Abstract][Full Text] [Related]
4. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
Maraki S; Mantadakis E; Samonis G
Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
[TBL] [Abstract][Full Text] [Related]
5. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
[TBL] [Abstract][Full Text] [Related]
6. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
Aguilar L; Giménez MJ
Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
[No Abstract] [Full Text] [Related]
7. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal resistance in the postvaccine era.
Temime L; Guillemot D; Boëlle PY
Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
[No Abstract] [Full Text] [Related]
9. [An update of Streptococcus pneumoniae: from genomic to clinic].
Wintenberger C
Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
[No Abstract] [Full Text] [Related]
10. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance.
Am J Health Syst Pharm; 1997 Mar; 54(5):575-8. PubMed ID: 9066871
[No Abstract] [Full Text] [Related]
11. Advances in pneumococcal antibiotic resistance.
Song JH
Expert Rev Respir Med; 2013 Oct; 7(5):491-8. PubMed ID: 24138693
[TBL] [Abstract][Full Text] [Related]
12. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
Singh J; Sundaresan S; Manoharan A; Shet A
Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
[TBL] [Abstract][Full Text] [Related]
13. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
Lynch JP; Zhanel GG
Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
[TBL] [Abstract][Full Text] [Related]
14. Understanding the burden of pneumococcal disease in adults.
Blasi F; Mantero M; Santus P; Tarsia P
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():7-14. PubMed ID: 22882668
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae Serotypes 9 and 14 Circulating in Brazil over a 23-Year Period Prior to Introduction of the 10-Valent Pneumococcal Conjugate Vaccine: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.
Pinto TC; Kegele FC; Dias CA; Barros RR; Peralta JM; Merquior VL; Carvalho MD; Chochua S; Hawkins P; McGee L; Teixeira LM
Antimicrob Agents Chemother; 2016 Nov; 60(11):6664-6672. PubMed ID: 27572394
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.
Pletz MW; McGee L; Jorgensen J; Beall B; Facklam RR; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2004 Sep; 48(9):3491-7. PubMed ID: 15328116
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
18. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group.
Jernigan DB; Cetron MS; Breiman RF
JAMA; 1996 Jan; 275(3):206-9. PubMed ID: 8604173
[TBL] [Abstract][Full Text] [Related]
19. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance of Streptococcus pneumoniae, isolated from nasopharynx of preschool children with acute respiratory tract infection in Lithuania.
Stacevičienė I; Petraitienė S; Vaičiūnienė D; Alasevičius T; Kirslienė J; Usonis V
BMC Infect Dis; 2016 May; 16():216. PubMed ID: 27206423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
